Diabetic retinopathy
Researchers from Gansu Provincial Hospital in Lanzhou, People's Republic of China, have conducted a systematic review and meta-analysis to evaluate the efficacy and safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents as an adjunct prior to pars plana vitrectomy (PPV) for patients with proliferative diabetic retinopathy (PDR)
Asian medicine
Researchers in Nanjing, People's Republic of China, have identified a correlation between inflammatory factors and the total load of cerebral small vessel disease in diabetic retinopathy and cognitive impairment. The study investigated 1860 patients with type 2 diabetes mellitus, dividing them into a diabetic retinopathy (DR) group and
Diabetic retinopathy
A team of researchers from Queen's University in Belfast, United Kingdom, has presented fresh data on diabetic retinopathy, a leading cause of blindness worldwide. The study, published in the BMJ Open Ophthalmology journal, examined the effects of repeated anti-vascular endothelial growth factor (VEGF) injections on the progression of
Diabetic retinopathy
Researchers at the University of Texas Rio Grande Valley have highlighted the crucial role of vascular endothelial growth factor (VEGF) in the development of age-related macular degeneration (AMD) and diabetic retinopathy (DR). According to the study, VEGF promotes retinal neovascularization and intraretinal fluid accumulation in DR, leading to complications like
